{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:42:46Z","timestamp":1793292166626,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Projects in Guangzhou, China","award":["2024A03J1157"],"award-info":[{"award-number":["2024A03J1157"]}]},{"name":"the Guangdong regional joint fund","award":["2022A1515110941"],"award-info":[{"award-number":["2022A1515110941"]}]},{"name":"the Guangdong Provincial Medical Science and Technology Research Fund","award":["B2023128"],"award-info":[{"award-number":["B2023128"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07460-3","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:49:45Z","timestamp":1755078585000},"page":"1004-1014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated [18F]FAPI-42 PET\/MR improves diagnostic accuracy in breast cancer: comparison with simultaneously acquired breast MRI"],"prefix":"10.1007","volume":"53","author":[{"given":"Peng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weige","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xigang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"7460_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7460_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12885-024-12844-z","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Sun H, Gao S, Kang Y, Shang C. Prediction of disease-free survival using strain elastography and diffuse optical tomography in patients with T1 breast cancer: a 10-year follow-up study. BMC Cancer. 2024;24:1057. https:\/\/doi.org\/10.1186\/s12885-024-12844-z.","journal-title":"BMC Cancer"},{"key":"7460_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227\u201336. https:\/\/doi.org\/10.1056\/NEJMoa062790.","journal-title":"N Engl J Med"},{"key":"7460_CR4","doi-asserted-by":"publisher","first-page":"djv367","DOI":"10.1093\/jnci\/djv367","volume":"108","author":"WA Berg","year":"2015","unstructured":"Berg WA, Bandos AI, Mendelson EB, Lehrer D, Jong RA, Pisano ED. Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666. J Natl Cancer Inst. 2015;108:djv367. https:\/\/doi.org\/10.1093\/jnci\/djv367.","journal-title":"J Natl Cancer Inst"},{"key":"7460_CR5","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/diagnostics12112741","volume":"12","author":"D Shahbazi-Gahrouei","year":"2022","unstructured":"Shahbazi-Gahrouei D, Aminolroayaei F, Nematollahi H, Ghaderian M, Gahrouei SS. Advanced magnetic resonance imaging modalities for breast Cancer diagnosis: an overview of recent findings and perspectives. Diagnostics (Basel). 2022;12:2741. https:\/\/doi.org\/10.3390\/diagnostics12112741.","journal-title":"Diagnostics (Basel)"},{"key":"7460_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00330-011-2238-8","volume":"22","author":"MN Plana","year":"2012","unstructured":"Plana MN, Carreira C, Muriel A, Chiva M, Abraira V, Emparanza JI, et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol. 2012;22:26\u201338. https:\/\/doi.org\/10.1007\/s00330-011-2238-8.","journal-title":"Eur Radiol"},{"key":"7460_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.12110853","volume":"266","author":"D Groheux","year":"2013","unstructured":"Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET\/CT in the clinical management of breast cancer. Radiology. 2013;266:388\u2013405. https:\/\/doi.org\/10.1148\/radiol.12110853.","journal-title":"Radiology"},{"issue":"suppl 1","key":"7460_CR8","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2967\/jnumed.115.157859","volume":"57","author":"D Groheux","year":"2016","unstructured":"Groheux D, Cochet A, Humbert O, Alberini J, Hindi\u00e9 E, Mankoff D. 18F-FDG PET\/CT for staging and restaging of breast Cancer. J Nucl Med. 2016;57(suppl 1):S17\u201326. https:\/\/doi.org\/10.2967\/jnumed.115.157859.","journal-title":"J Nucl Med"},{"key":"7460_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/j.semnuclmed.2021.04.005","volume":"51","author":"EG Kikano","year":"2021","unstructured":"Kikano EG, Avril S, Marshall H, Jones RS, Montero AJ, Avril N. PET\/CT variants and pitfalls in breast cancers. Semin Nucl Med. 2021;51:474\u201384. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.005.","journal-title":"Semin Nucl Med"},{"key":"7460_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A Tumor-Imaging method targeting Cancer-Associated fibroblasts. J Nucl Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"key":"7460_CR11","doi-asserted-by":"publisher","unstructured":"Guo W, Xu W, Meng T, Fan C, Fu H, Pang Y, et al. FAP-targeted PET\/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management. Eur J Nucl Med Mol Imaging. 2025;30. https:\/\/doi.org\/10.1007\/s00259-025-07108-2.","DOI":"10.1007\/s00259-025-07108-2"},{"key":"7460_CR12","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1097\/RLU.0000000000004523","volume":"48","author":"S Zheng","year":"2023","unstructured":"Zheng S, Lin J, Zhu Y, Chen Y, Zhang J, Chen X, et al. 68Ga-FAPI versus 18F-FDG PET\/CT in evaluating newly diagnosed breast Cancer patients. Clin Nucl Med. 2023;48:e104\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000004523.","journal-title":"Clin Nucl Med"},{"key":"7460_CR13","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1097\/RLU.0000000000004751","volume":"48","author":"G Al\u00e7\u0131n","year":"2023","unstructured":"Al\u00e7\u0131n G, Arslan E, Aksoy T, Cin M, Erol Fenercio\u011flu \u00d6, Beyhan E, et al. 68 Ga-FAPI-04 PET\/CT in selected breast Cancer patients with low FDG affinity: A Head-to-Head comparative study. Clin Nucl Med. 2023;48:e420\u201330. https:\/\/doi.org\/10.1097\/RLU.0000000000004751.","journal-title":"Clin Nucl Med"},{"key":"7460_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/diagnostics5030333","volume":"5","author":"U Bashir","year":"2015","unstructured":"Bashir U, Mallia A, Stirling J, Joemon J, MacKewn J, Charles-Edwards G, et al. PET\/MRI in oncological imaging: state of the Art. Diagnostics (Basel). 2015;5:333\u201357. https:\/\/doi.org\/10.3390\/diagnostics5030333.","journal-title":"Diagnostics (Basel)"},{"key":"7460_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1148\/radiol.2021204677","volume":"302","author":"P Backhaus","year":"2022","unstructured":"Backhaus P, Burg MC, Roll W, B\u00fcther F, Breyholz HJ, Weigel S, et al. Simultaneous FAPI PET\/MRI targeting the Fibroblast-Activation protein for breast Cancer. Radiology. 2022;302:39\u201347. https:\/\/doi.org\/10.1148\/radiol.2021204677.","journal-title":"Radiology"},{"key":"7460_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40658-016-0144-5","volume":"3","author":"M Conti","year":"2016","unstructured":"Conti M, Eriksson L. Physics of pure and non-pure positron emitters for PET: a review and a discussion. EJNMMI Phys. 2016;3:8. https:\/\/doi.org\/10.1186\/s40658-016-0144-5.","journal-title":"EJNMMI Phys"},{"key":"7460_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00259-024-06873-w","volume":"52","author":"T Liu","year":"2024","unstructured":"Liu T, Xu S, Cheng K, Pei J, Wang S, Li C, et al. Exploring the value of FAP-targeted PET\/CT in differentiating breast cancer molecular subtypes: a preliminary study. Eur J Nucl Med Mol Imaging. 2024;52:280\u201390. https:\/\/doi.org\/10.1007\/s00259-024-06873-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7460_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11307-021-01679-w","volume":"24","author":"Y Li","year":"2022","unstructured":"Li Y, Lin X, Li Y, Lv J, Hou P, Liu S, et al. Clinical utility of F-18 labeled fibroblast activation protein inhibitor (FAPI) for primary staging in lung adenocarcinoma: a prospective study. Mol Imaging Biol. 2022;24:309\u201320. https:\/\/doi.org\/10.1007\/s11307-021-01679-w.","journal-title":"Mol Imaging Biol"},{"key":"7460_CR19","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00330-015-4054-z","volume":"26","author":"D Botsikas","year":"2016","unstructured":"Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A, et al. Clinical utility of 18F-FDG-PET\/MR for preoperative breast cancer staging. Eur Radiol. 2016;26:2297\u2013307. https:\/\/doi.org\/10.1007\/s00330-015-4054-z.","journal-title":"Eur Radiol"},{"key":"7460_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2967\/jnumed.121.262009","volume":"62","author":"J Morawitz","year":"2021","unstructured":"Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, et al. Determining the axillary nodal status with four current imaging modalities including (18)F-FDG PET\/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard. J Nucl Med. 2021;62:1677\u201383. https:\/\/doi.org\/10.2967\/jnumed.121.262009.","journal-title":"J Nucl Med"},{"key":"7460_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jmri.26654","volume":"50","author":"RM Mann","year":"2019","unstructured":"Mann RM, Kuhl CK, Moy L. Contrast-enhanced MRI for breast cancer screening. J Magn Reson Imaging. 2019;50:377\u201390. https:\/\/doi.org\/10.1002\/jmri.26654.","journal-title":"J Magn Reson Imaging"},{"key":"7460_CR22","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","volume":"51","author":"SC Vaz","year":"2024","unstructured":"Vaz SC, Woll JPP, Cardoso F, Groheux D, Cook GJR, Ulaner GA, et al. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET\/CT in no special type breast cancer. Eur J Nucl Med Mol Imaging. 2024;51:2706\u201332. https:\/\/doi.org\/10.1007\/s00259-024-06696-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7460_CR23","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00330-017-5127-y","volume":"28","author":"C Spick","year":"2018","unstructured":"Spick C, Bickel H, Polanec SH, Baltzer PA. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis. Eur Radiol. 2018;28:1919\u201328. https:\/\/doi.org\/10.1007\/s00330-017-5127-y.","journal-title":"Eur Radiol"},{"key":"7460_CR24","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1158\/1078-0432.CCR-20-3037","volume":"27","author":"P Clauser","year":"2021","unstructured":"Clauser P, Krug B, Bickel H, Dietzel M, Pinker K, Neuhaus VF, et al. Diffusion-weighted imaging allows for downgrading MR BI-RADS 4 lesions in Contrast-enhanced MRI of the breast to avoid unnecessary biopsy. Clin Cancer Res. 2021;27:1941\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3037.","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07460-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:20Z","timestamp":1769222780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07460-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7460"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07460-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki and approved by the institutional review board (GZGYHR-2020-107).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a03, 4, 5 and 6 and S2.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}